Introduction
NK cells target infected, malignant, or allogeneic cells. These responses are controlled by activating or inhibitory receptors. The Ly49 (rodents), KIRs (human), or CD94/NKG2 receptor families recognize MHC class I, and lack of MHC class I leads to target cell lysis because of the lack of engagement by inhibitory receptors for MHC class I. This process is known as "missing self" recognition [1] . In addition, stress-induced ligands may be expressed, leading to engagement of activating receptors, such as NKG2D; the natural cytotoxicity receptors NKp30, NKp44, and NKp46; or activating members of the Ly49, CD94/NKG2, or KIR families. The NKR-P1 receptors, expressed by both rodent and human NK cells, may perform a parallel missing-self reaction upon interactions with their ligands Clr (rodents) and LLT1 (human) [2] [3] [4] . In particular, Clr-b expression has been shown to decrease during viral infection or tumor development in the mouse, similar to MHC class I [5] , and results in loss of inhibitory signal to NK cells via the inhibitory NKR-P1B receptor [6] . Inhibitory receptor/MHC class I interactions are also important for developing functional NK cells through the process of education [7] [8] [9] , in which more inhibitory receptors on NK cells correlate with increased functional ability [10] . Without that interaction, NK cells remain anergic or hyporesponsive [7, 8] . Recently, it was suggested that NKR-P1B and its ligand Clr-b serve a similar function in the mouse [6] .
NK cell receptors are expressed at different stages during development. In the rat, activating NKR-P1A is the first receptor detected in NK cells from newborns, followed by the inhibitory NKR-P1B, whereas expression of Ly49 receptors is modest at birth [11, 12] . Similarly, NKR-P1s are expressed before Ly49s in the mouse [13, 14] , whereas human inhibitory NKR-P1A is one of the earliest receptors expressed by immature human NK cells [15] .
Circulating NK cells consist of subsets of cells of varying degrees of maturity. In the mouse, it was previously demonstrated that immature and mature NK cells are distinguished by differential expression of CD27 and CD11b, where NK cells mature in the following sequence: CD11b low CD27 low → CD11b low CD27 hi → CD11b high CD27 high → CD11b high CD27 low [16, 17] . Different developmental stages of rat NK cells have not yet been characterized, but the circulating pool of rat NK cells can be divided based on almost mutually exclusive expression of NKR-P1B or Ly49s3 [11, 18] . The CD94/NKG2A receptor is coexpressed within the NKR-P1B + subset and the Ly49 receptors are restricted to the Ly49s3 + subset, thus dividing the major MHC I-binding receptors into distinct subsets. This partial separation of NKR-P1B vs. Ly49 expression is also observed in the mouse [13] and in humans, where subsets of CD56 dim NK cells express either NKG2A or KIR, although not on a mutually exclusive basis [19] [20] [21] . Rat NKR-P1B and Ly49s3 single-positive cells both show similar levels of IFN-g production and cytotoxicity, except toward allogeneic targets, which are only recognized and killed by Ly49s3 + NK cells [11, 18] . We previously identified a subset of rat NK cells lacking expression of both NKR-P1B and Ly49 receptors. That subset is present in all tissues, and we showed that, in the blood, the subset was hyporesponsive in terms of IFN-g production and cytotoxicity [22] . Here, we have characterized that subset further and show that its functional capacity is linked to induced expression of NKR-P1B. We further show that established maturation markers for mouse NK cells, CD27 and CD11b, are not optimal markers to distinguish immature from mature rat NK cells.
MATERIALS AND METHODS

Animals
Rats (8-12- 
Abs and reagents
Abs against NKp46 (Wen23-Pacific blue), NKR-P1A (3.2.3-Pacific blue), Ly49s5/i5 (Fly5-biotin), KLRH1 (STOK9-biotin), CD62L (OX85-biotin), CD25 (OX39-biotin), CD93 (Lov3-biotin), CD8a (OX8-biotin), CD90 (OX7-biotin), NKR-P1B (STOK27-Alexa 647), Ly49s3 (DAR13-FITC, -biotin), CD107a (SIM1-FITC), and CD45.2 (His41-FITC, biotin) were generated in our laboratory and conjugated according to standard protocols. Abs against NKG2A/C/E (Wen28-biotin) was a kind gift from Prof. E. Dissen, Oslo [unpublished results]. Abs against CD3 (G4.18-FITC), NKR-P1A (10/78-PE), CD11b (WT.5-biotin), CD27 (LG.3A10-PE), NKG2D (9C1164-PE), IFN-g (DB1-PE), FITC hamster IgG polyclonal isotype, CD195 (C34-3448-biotin; isotype control), mouse IgA isotype (M18-254-biotin), and streptavidin-PerCP were from BD Biosciences (Franklin Lakes, NJ, USA). AntiEomes (Dan11mag-PE) and Rat IgG2a isotype control (eBR2a-PE) were from eBioscience (San Diego, CA, USA). Anti-CD117 (RA14132) was from Neuromics (Edina, MN, USA), FITC anti-rabbit IgG was from Jackson ImmunoResearch Europe (Newmarket, Suffolk, United Kingdom), and anti-CD127 (FAB5607P-PE) was from R&D Systems (Minneapolis, MN, USA). Anti-KLH (G1-2-2-biotin; rat IgG1 isotype control) was from GeneTex (Irvine, CA, USA) and Pyk2 (17H4L19-unconjugated; rabbit IgG isotype control) was from Thermo Fisher Scientific (Waltham, MA, USA). rrIL-2 was obtained from dialyzed cell culture supernatants of a Chinese hamster ovary cell line stably transfected with a rat IL-2 expression construct. rrIL-12 was purchased from BioSource International (Camarillo, CA, USA), rrIL-15 from PeproTech (Rocky Hill, NJ, USA), and rrIL-18 from R&D Systems.
Flow cytometry and cell sorting
Spleens were crushed through 70-mM filters, and mononuclear cells were isolated using Lymphoprep (Axis-Shield Diagnostics, Dundee, Scotland, United Kingdom) overlays. Remaining RBCs were lysed and further incubated in nylon wool (Polysciences, Warrington, PA, USA) columns at 37°C to remove B cells and myeloid cells. 
Cell culture
Sorted NKR-P1B 2 ) NK cell subsets were cultured in cRPMI-1640, supplemented with 10% heat-inactivated FBS, 1% streptomycin/penicillin, 1 mM sodium pyruvate, 50 mM 2-Mercaptoethanol) containing 10 ng/ml IL-15 and 1/100 IL-2 for various time points. The mouse T cell lymphoma cell line YAC-1 (TIB-160; ATCC, Manassas, VA, USA) was maintained in cRPMI. 
Adoptive transfer
NKR-P1B
Statistical analysis
Graphics and statistical analysis were performed with Prism software (GraphPad Software, La Jolla, CA, USA). Data are presented as the means 6 SEM. Statistical significance was calculated using an unpaired t test with Welch's correction. P , 0.05 was considered statistically significant. (Fig. 1A and B) . In addition, lower degranulation by splenic NKR-P1B 2 Ly49s3 2 NK cells in response to the sensitive tumor target YAC-1 was observed (Fig. 1C and D) . In contrast, cytolytic activity of sorted NKR-P1B 2 Ly49s3 2 NK cells was not lower than that of Ly49s3 + NK cells, but only of NKR-P1B + NK cells (Fig. 1E) . The discrepancy between the degranulation and cytotoxicity assays for the Ly49s3 + subset was unexpected because we previously showed similar levels of perforin and granzyme B and the cytotoxic ability of blood-derived Ly49s3 + and NKR-P1B + subsets [22] . Fig. 2A) . The expression of NKR-P1B by NKR-P1B 2
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2 cells was detected as early as at 1 h of culture (Fig. 2B) . By 24 h, the expression of NKR-P1B was comparable to the levels observed by d 6. Many cells (Fig. 3A) . In parallel, the NKR-P1B + and Ly49s3 + subsets were also sorted and injected into separate hosts. After 2 wk, the spleen and blood were harvested, and the donor CD45.2 + cells were identified with an Ab against CD45.2 ( Fig. 3B and Supplemental Fig. 3 Fig. 4A and B) . The level of degranulation was comparable to that of bona fide NKR-P1B + cells, indicating that the newly formed NKR-P1B + cells gained similar functional response to NKR-P1A cross-linking. In contrast, no significant differences in degranulation against YAC-1 targets between NKR-P1B 2 Ly49s3 2 or newly formed NKR-P1B + NK cells were observed ( Fig. 4C and D) . Because responses to YAC-1 are mainly facilitated via NKG2D [23] , that discrepancy could reflect different responses of NKR-P1A and NKG2D.
Cells remaining double-negative have increased proliferative capacity
We next compared the proliferative activity of remaining NKR-P1B (Fig. 5A) . For the NKR-P1B
2 Ly49s3 2 subset, we observed a higher proliferation rate for cells that remained negative for NKR-P1B compared with newly formed NKR-P1B + cells that contained a large subset of cells with low proliferation levels (Fig. 5B ). (Fig. 6) . The transcription factor Eomes, which is expressed by conventional NK cells but not by other innate lymphoid cells [24] , was also expressed by most of the NKR-P1B 2
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2 cells (Fig. 6) 7A) . Further, the combined staining of CD27 and CD11b showed that most NKR-P1B 
2 NK cells were CD11b single-positive, indicative of a mature phenotype (Fig. 7B) , which was surprising because our data suggested the cells were less differentiated. CD11b and CD27 have been characterized as NK cell maturation markers in the mouse [16, 17] , and we tested whether those markers were applicable to rat NK cells. Subsets of splenic NK cells expressing CD27 and/or CD11b were sorted from CD45.2 + donor rats and injected into separate CD45.1 + hosts. We observed increased expression of CD11b by the transferred CD11b low CD27 low cells (Supplemental Fig. 4A and   B ), but the staining intensity was rather low when compared with the intensity of CD11b by host NK cells (Supplemental Fig. 4C ), and a large fraction remained CD11b low CD27 low .
Transferred CD11b high CD27 low cells remained remarkably stable, suggesting that those cells are unable to express CD27 (Supplemental Fig. 4A and B Fig. 4A and B) . We concluded that the combined use of CD27 and CD11b was not useful for defining stages of maturing rat NK cells. Based on available markers, we can, therefore, not define clearly whether NKR-P1B 
2 NK cells are mature or not.
DISCUSSION
In this study, we have characterized an NK cell subset defined by the absence of NKR-P1B and Ly49s3, which has the characteristics of a less-differentiated cell with potential for further differentiation to functionally competent cells linked to upregulation of NKR-P1B. 
A large fraction of NKR-P1B
2 Ly49s3 2 NK cells were induced to express NKR-P1B but very little Ly49s3. Up-regulation of NKR-P1B coincided with increased functional competence and reduced proliferative activity. Both human and mouse NK cells express NKR-P1s at the precursor stage, activating NKR-P1C in the mouse and inhibitory NKR-P1A in the human [27] . Activating NKR-P1A and inhibitory NKR-P1B are also present early in NK cell development in the rat [12] . Expression of Ly49s and KIRs are expressed later in ontogeny in both rodents and humans, implying that, in those species, NKR-P1s are expressed before MHC class I binding receptors [14, 15] . NKR-P1B 2 Ly49s3 2 cells follow that expected line of differentiation, with early NKR-P1B expression followed by Ly49 at later stages in vitro. Expression of NKR-P1B was detected after only 1 h culture with IL-2 and IL-15. Semiquantitative RT-PCR studies on sorted NKR-P1B 2 Ly49s3 2 blood NK cells showed the presence of NKR-P1B transcripts (data not shown), further rationalizing the hypothesis that some of the cells may have intracellular NKR-P1B protein and are preprogrammed to express NKR-P1B. NKR-P1B was recently shown to have a possible role in education/licensing [6] . With no Ly49 or NKR-P1B expression, NKR-P1B
2 Ly49s3 2 NK cells may be hyporesponsive because of a limited ability to interact with self and thereby become educated through inhibitory receptors for self. Induction of NKR-P1B expression coincided with increased degranulative ability in response to NKR-P1A, which may be the result of an education process occurring when NKR-P1B interacts with its ligand Clr11. Gene transcripts for Clr11 are found in most hematopoietic cells, including activated NK cells [28, 29] . This indicates that the NKR-P1B 2 Ly49s3 2 cells may express Clr11, allowing the purified population to become educated in vitro upon expression of NKR-P1B. However, it was surprising that no difference in degranulation was measured between bona fide NKR-P1B + NK cells, newly expressing NKR-P1B + cells, and cells that remained NKR-P1B 
Ly49s3
2 when YAC-1 targets were used as a stimulus.
The cells were cultured overnight in the presence of IL-2, which could potentially mask the more general response toward a highly sensitive tumor target. In addition, responses to YAC-1 were mainly facilitated via NKG2D [23] , and low phenotype (data not shown). By adoptively transferring the different CD11b/CD27 subsets, we observed that NK cell maturation defined by CD27 and CD11b expression is not clearcut in the rat and conclude that CD27 and CD11b cannot be used as maturation markers for rat NK cells. Even though we could not define maturation status of the NKR-P1B 2
2 subset based on phenotypic markers, it is clear that this subset is a precursor to the NKR-P1B + subset because of its induced expression of NKR-P1B both in vitro and in vivo. A recent study in mouse demonstrated that sorted NKR-P1B
2 cells changed to express NKR-P1B when cultured in IL-2, suggesting that this developmental pathway takes place in the mouse as well [6] .
In conclusion, we report that a subset of rat NK cells lacking expression of NKR-P1B and Ly49s3 with decreased function that develop into functionally mature NKR-P1B + NK cells both in vivo and in vitro. Future studies are required to further understand the development of distinct subsets of NK cells in different tissues. 
